Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Stephanie Bogan Grantor
Award ceiling
—Award floor
—Posted
Jul 11, 2025Closes
Feb 8, 2028Location eligibility
No specific state restriction found in this listing — check the full opportunity for details.Categories: Agriculture, Consumer Protection, Food and Nutrition
Eligible applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Description
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.